Classification of vascular anomalies and the comprehensive treatment of hemangiomas

Plastic and Reconstructive Surgery

Volumn 124, Issue SUPPL. 1, 2009, Pages

  Burns, A Jay ^a   Navarro, J Alberto ^a   Cooner, Rebecca D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; CONGENITAL BLOOD VESSEL MALFORMATION; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; HEMANGIOMA; HUMAN; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM MALFORMATION; NEVUS FLAMMEUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT SATISFACTION; PEDIATRIC SURGERY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; VASCULAR SURGERY; VEIN MALFORMATION;

ALGORITHMS; ARTERIOVENOUS MALFORMATIONS; HEMANGIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; PORT-WINE STAIN; TREATMENT OUTCOME; VASCULAR MALFORMATIONS;

EID: 68049115653     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181aa1015     Document Type: Review

References (56)

1. Mulliken JB, Young AE. Vascular birthmarks in folklore, history, art, and literature. In: Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: Saunders; 1988:3-23.
2. Kenkel JM. Vascular anomalies and lymphedema. Select Read Plast Surg. 2000;9:1.
3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-420.
4. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations: New issues. Adv Dermatol. 1998;13:375-423.
5. Waner M, Suen JY. A classification of congenital vascular lesions. In: Waner M, Suen JY, eds. Hemangiomas and Vascular Malformations of the Head and Neck. New York: Wiley-Liss; 1999:1-12.
6. Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 1982;92:328-353.
7. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
8. Barsky SH, Rosen S, Geer DE, Noe JM. The nature and evolution of port-wine stains: A computer-assisted study. J Invest Dermatol. 1980;74:154-157.
9. Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991;17:76-79.
10. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 1990:689-690.
11. Selim MM, Kelly KM, Nelson JS, Wendelschafer-Crabb G, Kennedy WR, Zelickson BD. Confocal microscopy study of nerves and blood vessels in untreated and treated port wine stains: Preliminary observations. Dermatol Surg. 2004;30:892-897.
12. Fiskerstrand EJ, Svaasand LO, Kopstad G, Dalaker M, Norvang LT, Volden G. Laser treatment of port wine stains: Therapeutic outcome in relation to morphological parameters. Br J Dermatol. 1996;134:1039-1043.
13. Rydh M, Malm M, Jernbeck J, Dalsgaard CJ. Ectatic blood vessels in port-wine stains lack innervation: Possible role in pathogenesis. Plast Reconstr Surg. 1991;87:419-422.
14. Lanigan SW, Cotterill JA. Objective assessments of port wine stains: Response to temperature change. Br J Dermatol. 1988;118:803-809.
15. Smoller BR, Rosen S. Port-wine stains: A disease of altered neural modulation of blood vessels? Arch Dermatol. 1986;122:177-179.
16. Mills CM, Lansigan SW, Hughes J, Anstey AV. Demographic study of port wine stain patients attending a laser clinic: Family history, prevalence of naevus anaemicus and result of prior treatment. Clin Exp Dermatol. 1997;22:166-168.
17. Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 1991;87:323-327.
18. Enjolras O, Rich MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics 1985;76:48-51.
19. Stevenson RF, Thomson HG, Morin JD. Unrecognized ocular problems associated with port wine stains of the face in children. Can Med Assoc J. 1974;111:953-955.
20. Bodensteiner JB, Roach ES. Sturge-Weber Syndrome. Mt. Freedom, N.J.: The Sturge-Weber Foundation; 1999.
21. Pascual-Castroviejo I, Diaz-Gonzalez C, Garcia-Melian RM, Gonzalez-Casado I, Munoz-Hiraldo E. Sturge-Weber syndrome: Study of 40 patients. Pediatr Neurol. 1993;9:283-288.
22. Arzimanoglou AA, Andermann F, Aicardi J, et al. Sturge-Weber syndrome: Indications and results of surgery in 20 patients. Neurology 2000;55:1472-1479.
23. Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: Clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. 1995;95:951-960.
24. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998;16:455-488.
25. Pratt AG. Birthmarks in infants. AMA Arch Dermatol Syphilol. 1967;67:302-305.
26. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
27. Jacobs AH. Strawberry hemangiomas: The natural history of the untreated lesion. Calif Med. 1957;86:8-10.
28. Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol. 1960;82:667-680.
29. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg. 1983;18:894-900.
30. Margileth AM, Museles M. Cutaneous hemangiomas in children: Diagnosis and conservative management. JAMA. 1965;194:523-526.
31. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986;3:331-332.
32. Takahashi K, Mulliken JB, Lozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.
33. Pasyk KA, Cherry GW, Grabb WC, Sasaki GH. Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plast Reconstr Surg. 1984;73:69-77.
34. Hopfel-Kreiner I. Histogenesis of hemangiomas: An ultrastructural study on capillary and cavernous hemangiomas of the skin. Pathol Res Pract. 1980;170:70-90.
35. Hidano A, Nakajima S. Earliest features of the strawberry mark in the newborn. Br J Dermatol. 1972;87:138-144.
36. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48:477-496.
37. Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma: Clinical and histopathologic features. Pediatr Dev Pathol. 2003;6:495-510.
38. North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC Jr. Congenital nonprogressive hemangioma: A distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol. 2001;137:1607-1620.
39. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol. 1999;29:879-893.
40. Burrows PE, Robertson RL, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: Angiographic differentiation. AJR Am J Roentgenol. 1983;141:483-488.
41. Waner M, Suen JY. Treatment of hemangiomas of the head and neck. Laryngoscope 1992;102:1123-1132.
42. Mazzola RF. Treatment of hemangiomas in children by intralesional injections of steroids. Chir Plast (Berl.) 1978;4:161.
43. Abe S. Local steroid therapy of adnexal strawberry hemangiomas in infants: Long term follow-up. Eur J Plast Surg. 1986;9:29.
44. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: A review of 155 cases. J Pediatr Surg. 2000;35:420-423.
45. Boyd MJ, Collin JRO. Capillary hemangiomas: An approach to their management. Br J Ophthalmol. 1991;75:298-300.
46. Weiss AH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1989;107:518-522.
47. Glatt HJ, Putterman AM, Van Aalst JJ, Levine MR. Adrenal suppression and growth retardation after injection of periocular capillary hemangioma with corticosteroids. Ophthalmic Surg. 1991;22:95-97.
48. Kushner BJ. Intralesional corticosteroid injection for infantile adnexal hemangioma. Am J Ophthalmol. 1982;93:496-506.
49. Townsend LM, Buckley EG. Linear subcutaneous fat atrophy after a single corticosteroid injection for ocular adnexal hemangioma. Am J Ophthalmol. 1990;109:102-103.
50. Dunston FM, Codere F. Perilymphatic subcutaneous atrophy in adnexal hemangioma: A complication of intralesional corticosteroid injection. Ophthalmic Surg. 1990;21:215-217.
51. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104:1616-1623.
52. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol. 2001;137:1208-1213.
53. Brown SH, Neerhout RC, Fonkalsrud ED. Prednisone therapy in the management of large hemangiomas in infants and children. Surgery 1972;71:168-173.
54. White C, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr. 1991;118:59-66.
55. White CW, Korones DN, Tosi MF. On interferon alfa in the treatment of hemangiomas (Letter). J Pediatr. 1991;119:676.
56. Mulliken JB, Rogers GF, Marler J. Circular excision of the hemangioma and purse-string closure: The smallest possible scar. Plast Reconstr Surg. 2002;109:1544-1555; discussion 1555.